Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-28

Clinical Trial Update: Role of Programmed Death Ligand 1 in Colorectal Cancer

View source ↗

Summary

A clinical trial led by Assiut University is investigating the role of PD-L1 in colorectal cancer, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Colo-rectal Cancer | Status: NOT_YET_RECRUITING